We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JMOM icon
3126
JPMorgan US Momentum Factor ETF
JMOM
$2.41B
$488K ﹤0.01%
8,548
-1,519
-15% -$82.7K
FER icon
3127
Ferrovial N.V. Ordinary Shares
FER
$44.7B
$488K ﹤0.01%
11,411
-466
-4% -$19K
DLB icon
3128
Dolby
DLB
$4.97B
$488K ﹤0.01%
6,376
-464,894
-99% -$34.6M
FLQL icon
3129
Franklin US Large Cap Multifactor Index ETF
FLQL
$1.99B
$487K ﹤0.01%
8,376
-4,503
-35% -$253K
IFLN
3130
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$308M
$487K ﹤0.01%
26,270
+7,806
+42% +$143K
MDU icon
3131
MDU Resources
MDU
$4.18B
$486K ﹤0.01%
31,985
-187,440
-85% -$2.67M
TQQQ icon
3132
ProShares UltraPro QQQ
TQQQ
$28.6B
$486K ﹤0.01%
+13,400
New +$460K
OBK icon
3133
Origin Bancorp
OBK
$1.7B
$482K ﹤0.01%
14,978
+257
+2% +$8.37K
GTLB icon
3134
GitLab
GTLB
$5.75B
$481K ﹤0.01%
9,338
+2,394
+34% +$120K
PBE icon
3135
Invesco Biotechnology & Genome ETF
PBE
$286M
$481K ﹤0.01%
6,891
-252
-4% -$17.4K
ALTM
3136
DELISTED
Arcadium Lithium plc
ALTM
$480K ﹤0.01%
168,417
-7,305
-4% -$21.1K
DBND icon
3137
DoubleLine Opportunistic Bond ETF
DBND
$738M
$480K ﹤0.01%
10,129
+670
+7% +$31.2K
BMN icon
3138
BlackRock 2037 Municipal Target Term Trust
BMN
$157M
$479K ﹤0.01%
18,724
-8,092
-30% -$202K
FT
3139
Franklin Universal Trust
FT
$198M
$478K ﹤0.01%
63,273
+242
+0.4% +$1.73K
SMAY icon
3140
FT Vest US Small Cap Moderate Buffer ETF May
SMAY
$109M
$478K ﹤0.01%
19,448
+1,757
+10% +$42.2K
GNMA icon
3141
iShares GNMA Bond ETF
GNMA
$423M
$478K ﹤0.01%
10,669
+1
+0% +$44
XJR icon
3142
iShares ESG Screened S&P Small-Cap ETF
XJR
$184M
$478K ﹤0.01%
11,426
+10
+0.1% +$403
TECB icon
3143
iShares US Tech Breakthrough Multisector ETF
TECB
$447M
$477K ﹤0.01%
9,307
-173
-2% -$8.59K
FTAI icon
3144
PUT
FTAI Aviation
FTAI
$20.2B
$475K ﹤0.01%
+5,000
New +$567K
RUSHA icon
3145
Rush Enterprises Class A
RUSHA
$6.34B
$475K ﹤0.01%
8,989
-302
-3% -$15K
MPV
3146
Barings Participation Investors
MPV
$175M
$474K ﹤0.01%
27,995
+113
+0.4% +$1.84K
EWL icon
3147
iShares MSCI Switzerland ETF
EWL
$2.17B
$474K ﹤0.01%
9,094
+1,222
+16% +$61.8K
RLAY icon
3148
Relay Therapeutics
RLAY
$4B
$473K ﹤0.01%
66,842
+29,865
+81% +$223K
ADSE icon
3149
ADS-TEC Energy
ADSE
$908M
$473K ﹤0.01%
35,331
OTEX icon
3150
Open Text
OTEX
$6.28B
$471K ﹤0.01%
+14,151
New +$446K

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.